Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 1344397)

Published in Ann Surg on September 01, 1976

Authors

J S Najarian, R L Simmons, R M Condie, E J Thompson, D S Fryd, R J Howard, A J Matas, D E Sutherland, R M Ferguson, J R Schmidtke

Articles citing this

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89

Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60

A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15

Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13

A 14-year experience with kidney transplantation. World J Surg (1977) 0.88

Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg (1991) 0.87

The value of needle renal allograft biopsy. I. A retrospective study of biopsies performed during putative rejection episodes. Ann Surg (1983) 0.85

Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins. Immunology (1992) 0.82

100 HLA-identical sibling transplants. Prognostic factors other than histocompatibility. Ann Surg (1979) 0.79

The effect of serum ALG concentrations on results following renal transplantation. Ann Surg (1977) 0.78

Current trends in the treatment of uraemia: a view from the United States. Br Med J (1979) 0.75

The mechanism behind the effect of ALG on platelets in vivo. Clin Exp Immunol (1977) 0.75

When should the third renal transplant rejection episode be treated? Ann Surg (1977) 0.75

Articles cited by this

Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer (1973) 14.90

Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22

Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1966) 7.56

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

THE EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Ann N Y Acad Sci (1964) 3.79

A simple micro cytotoxicity test. Transplantation (1969) 3.67

Allograft survival: effect of antiserums to thymus glands and lymphocytes. Science (1965) 2.45

Adult Thymectomy: Effect on Recovery from Immunologic Depression in Mice. Science (1965) 2.41

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

Some effects of purified heterologous antihuman lymphocyte serum in man. Transplantation (1967) 1.62

The effect of heterologous immune serum on canine renal homografts. Transplantation (1966) 1.52

A trial with heterologous antilymphocyte globulin in man. Transplant Proc (1969) 1.51

Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37

Renal transplantation in high-risk patients. Arch Surg (1971) 1.28

The clinical use of antilymphocyte globulin. N Engl J Med (1971) 1.24

Further developments of the rosette inhibition test for the testing of antihuman lymphocyte serum. Transplantation (1971) 1.21

EFFECTS OF RABBIT ANTI-RAT-LYMPHOCYTE PLASMA ON IMMUNE RESPONSE OF RATS THYMECTOMISED IN ADULT LIFE. Lancet (1965) 1.12

Antilymphocyte globulin in patients with renal allografts from cadaveric donors. Late results of a controlled trail. Lancet (1973) 1.04

Reversible dissociation of fragment Fc of rabbit gamma-G-immunoglobulin. J Biol Chem (1966) 1.00

Survey of the current status of the clinical uses of antilymphocyte serum. Surg Gynecol Obstet (1976) 0.95

Anti-HL-A antibodies: Failure to correlate with renal allograft rejection. Surgery (1974) 0.95

Antithymocyte globulin in renal transplant krecipients. A clinical trial. Arch Surg (1973) 0.93

Antiserum to lymphocytes: interactions with chemical immunosuppressants. Science (1968) 0.93

The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts. Transplant Proc (1969) 0.91

The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line. Cancer Res (1974) 0.89

Immunosuppressive assay of antilymphoblast globulin in man: effect of dose, histocompatibility, and serologic response to horse gamma globulin. Surgery (1970) 0.88

Renal transplantation for diabetic glomerulosclerosis. Ann Surg (1973) 0.88

Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine. Ann Surg (1968) 0.86

Platelet activity of antilymphocyte serum (ALS) preparations. Transplant Proc (1973) 0.83

Parent-to-child and child-to-parent kidney transplants. Experience with 101 transplants at one centre. Lancet (1976) 0.83

Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results. Transplant Proc (1971) 0.83

A fibrinogen-free plasma perfusate for preservation of kidneys for one hundred and twenty hours. Surg Gynecol Obstet (1974) 0.81

The clinical application of a new prosthetic arteriovenous shunt. Characteristics and advantages over the standard A-V shunt and the A-V fistula. Nephron (1974) 0.78

Forced flow electrophoretic purification of anti-human antilymphoblast globulin. Surgery (1970) 0.78

Articles by these authors

Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell (1995) 9.31

Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06

Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol (1998) 7.84

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60

Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes. J Exp Med (1984) 4.88

Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78

A mechanism for surface attachment in spores of a plant pathogenic fungus. Science (1988) 4.32

Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30

Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30

20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88

Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80

Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1996) 3.55

Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature (1985) 3.53

Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol (1986) 3.51

Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science (1986) 3.47

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42

Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42

Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31

Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc Natl Acad Sci U S A (1986) 3.29

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11

Central nervous system sarcoidosis--diagnosis and management. QJM (1999) 3.11

Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00

A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78

Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75

Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66

Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. Blood (1997) 2.56

A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell (1987) 2.53

Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49

Immunodepression after major surgery in normal patients. Surgery (1975) 2.48

Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46

Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology (1987) 2.45

Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44

Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes. J Immunol (1983) 2.43

Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41

Research toward malaria vaccines. Science (1986) 2.40

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40

Knob-positive and knob-negative Plasmodium falciparum differ in expression of a strain-specific malarial antigen on the surface of infected erythrocytes. J Exp Med (1984) 2.38

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34

Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion. J Immunol (1981) 2.33

Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32

An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27

Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25

Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25

Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24

Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18

Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood (1991) 2.18

Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16

Renal transplantation in older people. Lancet (1994) 2.15

A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11

Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11

Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria. Infect Immun (1983) 2.10

Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol (1997) 2.09

Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07

Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04

Tomato Ve disease resistance genes encode cell surface-like receptors. Proc Natl Acad Sci U S A (2001) 2.03

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry (1996) 2.02

The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci (1998) 2.01

Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01

Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00

American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00

Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00

Activation of purified human thymus-derived (T) cells by mitogens. II. Monocyte- macrophage potentiation of mitogen-induced DNA synthesis. J Immunol (1976) 2.00

Immune response to a hapten coupled to a nonimmunogenic carrier. Influence of lipopolysaccharide. J Exp Med (1972) 1.95

Effects of MBC on hyphal tip organization, growth, and mitosis of Fusarium acuminatum, and their antagonism by D2O. Protoplasma (1977) 1.91

Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90

Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89

Plasmodium falciparum malaria: association of knobs on the surface of infected erythrocytes with a histidine-rich protein and the erythrocyte skeleton. J Cell Biol (1984) 1.88

Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86

Corynebacterium equi: a review of 12 cases of human infection. Rev Infect Dis (1984) 1.85

Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. Proc Natl Acad Sci U S A (1983) 1.83

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83

The pathology of human cerebral malaria. Am J Trop Med Hyg (1990) 1.82

Pancreatic trauma: a review. Surgery (1972) 1.81

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80

Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79

The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg (1997) 1.79